GSK GlaxoSmithKline PLC ADRs

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.

$43.75  +0.22 (0.51%)
As of 07/01/2022 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  09/04/2001
Outstanding shares:  2,541,795,154
Average volume:  6,365,695
Market cap:   $111,254,373,891
Current dividend yield:  4.46%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2374112
Valuation   (See tab for details)
PE ratio:   17.49
PB ratio:   6.77
PS ratio:   2.43
Return on equity:   31.60%
Net income %:   14.02%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy